文献速递主动脉疾病

择期开窗/分支腔内修复复杂腹主动脉及胸腹主动脉瘤的中长期结局:系统综述与荟萃分析

Editor's Choice - Medium and Long Term Time to Event Outcomes after Elective Fenestrated and or Branched Endovascular Repair of Complex Abdominal and Thoraco-abdominal Aortic Aneurysms: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2026-06-05

汇总5年总生存率为55.4%,动脉瘤相关死亡免除率为96.4%,再干预免除率为66.5%,证据确定性低至非常低。

要点

  • 择期开窗/分支腔内修复后5年总生存率55.4%,中位总生存期6.36年。
  • 5年动脉瘤相关死亡免除率96.4%,再干预免除率66.5%。
  • 靶血管通畅率94.8%(基于两项研究),证据确定性非常低。

核心结论

  • 择期开窗和/或分支腔内修复可实现持久的动脉瘤隔绝,动脉瘤相关死亡率低。
  • 但5年后生存率显著下降,需要更稳健的生存数据及改进工具支持患者选择与共享决策。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library(2000年1月至2026年2月),辅以引文筛选。
  • 采用经验证的方法生成汇总生存概率,使用GRADE框架评估证据确定性,ROBINS-I(v2)评估偏倚风险。
  • 方案注册于PROSPERO(CRD42024565664)。

主要发现

  • 汇总总生存率:1年91.3%(95%CI 90.7-91.9),3年73.0%(95%CI 71.9-74.0),5年55.4%(95%CI 53.9-56.8)。
  • 估计中位总生存期为6.36年。
  • 基于报告该结局的研究,5年动脉瘤相关死亡免除率为96.4%(95%CI 95.3-97.2),再干预免除率为66.5%(95%CI 64.6-68.2)。
  • 基于两项研究,靶血管通畅率为94.8%(95%CI 93.3-96.0)。

关键数值与推荐

  • 总生存率、动脉瘤相关死亡免除率和再干预免除率的证据确定性为低。
  • 靶血管通畅率的证据确定性为非常低。

临床怎么用

  • 择期开窗/分支腔内修复可用于复杂腹主动脉及胸腹主动脉瘤的预防性治疗,动脉瘤相关死亡风险低。
  • 术后5年后生存率明显下降,临床决策时应充分告知患者中长期生存预期与再干预风险。
  • 需结合患者选择工具和共享决策评估预期获益,尤其考虑预防性复杂腔内修复时。

局限性

  • 总生存率、动脉瘤相关死亡免除率和再干预免除率的证据确定性低,靶血管通畅率证据确定性非常低。
  • 靶血管通畅率仅基于两项研究。
  • 原始研究为非随机设计,存在相应偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To define contemporary medium (3 - 5 years) and long term (> 5 years) survival and durability outcomes after elective fenestrated and or branched endovascular aortic repair for complex abdominal and thoraco-abdominal aneurysms and to assess the certainty of the available evidence. DATA SOURCES: MEDLINE, Embase, and Cochrane Library. REVIEW METHODS: MEDLINE, Embase, and the Cochrane Library were searched from January 2000 to February 2026, supplemented by citation screening. Published Kaplan-Meier time to event data were digitised and reconstructed into individual patient datasets. Pooled survival probabilities were generated using validated methods for meta-analytic methods for survival curves. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation framework, and risk of bias was assessed with Risk of Bias in Non-Randomised Studies - of Interventions (ROBINS-1) (v2). The protocol was registered in the International Prospective Register of Systematic Reviews (CRD42024565664). RESULTS: Twenty four studies comprising 8 886 patients were included. Pooled overall survival was 91.3% (95% confidence interval [CI] 90.7 - 91.9) at one year, 73.0% (95% CI 71.9 - 74.0) at three years, and 55.4% (95% CI 53.9 - 56.8) at five years. Estimated median overall survival was 6.36 years. Based on studies that reported this, at five years, freedom from aneurysm related death was 96.4% (95% CI 95.3 - 97.2), and freedom from re-intervention was 66.5% (95% CI 64.6 - 68.2). Target vessel patency, based on two studies, was 94.8% (95% CI 93.3 - 96.0). Certainty of evidence was low for overall survival, freedom from aneurysm related death and re-intervention, and very low for target vessel patency. CONCLUSION: Elective fenestrated and or branched endovascular aortic repair provides durable aneurysm exclusion with a low aneurysm related mortality rate. However, survival beyond five years declines substantially. There is a need for more robust survival data and improved tools to support patient selection, shared decision making, and assessment of anticipated benefit when considering prophylactic complex endovascular repair.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Yiu J, Abdelhalim MA, Guéroult AM, et al. Editor's Choice - Medium and Long Term Time to Event Outcomes after Elective Fenestrated and or Branched Endovascular Repair of Complex Abdominal and Thoraco-abdominal Aortic Aneurysms: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg. 2026. PMID: 42250598. doi:10.1016/j.ejvs.2026.06.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。